Isolation and study of the anthrax protective antigen. IV. The harmlessness, reactogeneity and efficacy of a concentrated, purified sorbed, chemical anthrax vaccine.
D000818:Animals; D000881:Anthrax / Q000276:immunology*; D000917:Antibody Formation / Q000187:drug effects; D000942:Antigens, Bacterial / Q000302:isolation & purification*; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000302:isolation & purification* / Q000633:toxicity; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006168:Guinea Pigs; D000882:Haplorhini; D006801:Humans; D007114:Immunization; D007115:Immunization Schedule; D007928:Lethal Dose 50; D051379:Mice; D010215:Papio; D011817:Rabbits; D013997:Time Factors; D014613:Vaccines, Attenuated; D014774:Virulence
D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D014613:Vaccines, Attenuated
Poluchenie i izuchenie sibiriazvennogo protektivnogo antigena. Soobshchenie IV. Bezvrednost', reaktogennost' i éffektivnost' kontsentrirovannoĭ ochishennoĭ sorbirovannoĭ khimicheskoĭ sibireiazvennoĭ vaktsiny.